Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131415) titled 'The effect of esketamine on postoperative depression in gynecological patients' on Sept. 2.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Yijishan Hospital of Wannan Medical college
Condition:
Perioperative depression
Intervention:
Esk group:Esketamine 0.4 mg/kg infused intravenously over 20 minutes after anesthesia induction
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-04
Target Sample Size: Esk group:70;control group:70;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=340852
Disclaimer...